NEW HAVEN, Conn., Aug. 01, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...
Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV) in the ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the ...
BULAPE, Congo — The World Health Organization announced that the last Ebola patient in Congo’s latest outbreak was discharged over the weekend and no new cases have been reported since Sept. 25.
Phase 2b Elumina trial; topline data anticipated in Q4 2026 (ClinicalTrials.gov: NCT06524830) AtaiBeckley plans to advance VLS-01 into major depressive disorder (MDD) in Phase 3, with generalized ...
The World Health Organization announced that the last Ebola patient in Congo's latest outbreak was discharged over the weekend and no new cases have been reported since Sept. 25. Sunday's announcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results